Key result
Variation in the size of intestinal loops during gastric bypass did not significantly influence the remission of diabetes (83-85%) or hypertension (62.5-68.4%) at 24 months.
Why the study?
Does variation in the size of intestinal loops during gastric bypass improve metabolic syndrome outcomes in obese diabetic patients?
Cohort (n=63)
Does variation in the size of intestinal loops during gastric bypass improve metabolic syndrome outcomes in obese diabetic patients?
Variation in the size of intestinal loops during gastric bypass does not significantly influence the improvement of metabolic syndrome parameters in obese diabetic patients.
Loop size variation during gastric bypass does not affect metabolic remission; leaves open the role of other technical factors in observational bariatric data.
Background: There is no consensus on the ideal size of intestinal loops in gastric bypass of bariatric surgeries. Aim: To evaluate the metabolic outcome of patients submitted to gastric bypass with alimentary and biliopancreatic loops of different sizes. Methods: Was conducted a retrospective cohort study in diabetic obese patients (BMI≥35 kg/m2) with metabolic syndrome submitted to gastric bypass. The patients were divided into three groups according to the size of the intestinal loop: group 1, biliopancreatic limb 50 cm length and alimentary limb 100 cm length; group 2 , biliopancreatic limb 50 cm length and alimentary limb 150 cm length; and group 3, biliopancreatic limb 100 cm length and alimentary limb 150 cm length. The effect of gastric bypass with different sizes of intestinal loops in relation to the parameters that define metabolic syndrome was determined. Results: Sixty-three patients were evaluated, and they had a mean age of 44.7±9.4 years. All were diabetics, with 62 (98.4%) being hypertensive and 51 (82.2%) dyslipidemic. The three groups were homogeneous in relation to the variables. In 24 months, there was a remission of systemic arterial hypertension in 65% of patients in group 1, 62.5% in group 2 and 68.4% in group 3. Remission of diabetes occurred in 85% of patients in group 1, 83% in group 2 and 84% in group 3. There was no statistical difference in %LEW between the groups, and waist measurements decreased in a homogeneous way in all groups. The size of loops also had no influence on the improvement in dyslipidemia. Conclusion: Variation in size of intestinal loops does not appear to influence improvement in metabolic syndrome in this group of patients.
No takes yet. Share an insight, caveat, or question.
Ramos et al. (2016) conducted a cohort in Obesity with metabolic syndrome and diabetes (n=63). Gastric bypass with varying intestinal loop sizes vs. Different loop sizes (Groups 1, 2, and 3) was evaluated on Metabolic syndrome parameters (remission of hypertension and diabetes, %LEW, waist measurements, dyslipidemia). Variation in the size of intestinal loops during gastric bypass did not significantly influence the remission of diabetes (83-85%) or hypertension (62.5-68.4%) at 24 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: